Filing Flows › Rafael Holdings (RFL) › Recalls, complaints & regulation
Rafael Holdings (RFL): clinical trials
Rafael Holdings (RFL) beyond its filings: 1 active clinical trial.
Rafael Holdings' latest quarter
Rafael Holdings, Q4 FY26: revenue $244K (-30% year over year), net loss $8.9M, operating cash flow −$8.4M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Rafael Holdings have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.